A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

The brands Rybelsus and Ozempic are currently FDA-approved for diabetes management, and Wegovy is used to assist with weight loss ... in the semaglutide group had better outcomes from non-invasive ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...

Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...